Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Maxim Group Maintains Buy on Palisade Bio, Adjusts Price Target To $22.5 (reverse stock split 1:15)

Author: Benzinga Newsdesk | April 16, 2024 01:27pm

Maxim Group analyst Naz Rahman maintains Palisade Bio (NASDAQ:PALI) with a Buy, adjusts target to $22.5 from $22.5 (reverse stock split 1:15).

Posted In: PALI